Company Filing History:
Years Active: 2019-2024
Title: Innovator Wenhua Huang: Pioneering Advancements in Anti-Her2 Therapies
Introduction
Wenhua Huang is a notable inventor based in Shanghai, China, recognized for his significant contributions to the field of biomedical innovations. With a total of four patents to his name, he has focused his research on advancing novel therapies for Her2 positive tumors, showcasing his commitment to improving patient outcomes.
Latest Patents
Huang's latest patents include groundbreaking work on an anti-Her2 nanobody and a coding sequence, aimed at combating the human epidermal growth factor receptor-2 (Her2/ERBB2). This invention provides a comprehensive solution, including the nanobody, a gene sequence encoding the nanobody, a corresponding expression vector, and a host cell capable of expressing the nanobody. Moreover, the invention outlines a method for producing this nanobody and its relevant applications. It also proposes an immunoconjugate of the nanobody, particularly useful in the diagnosis and treatment of Her2 positive tumors.
Additionally, another patent closely related to this research is the development of an anti-Her2 single chain antibody. This innovation shares similar technological foundations and aims to assist in the diagnosis and therapy of Her2 positive conditions, further emphasizing Huang's dedication to impactful medical advancements.
Career Highlights
Wenhua Huang has worked with esteemed organizations such as Henkel IP & Holding GmbH and Nanomab Technology Limited, where he has leveraged his expertise to drive significant research initiatives forward. His time in these companies has been instrumental in developing solutions aimed at addressing critical healthcare challenges.
Collaborations
Throughout his career, Huang has collaborated with talented individuals in the field, including Jie Cao and Allison Yue Xiao. These professional partnerships have not only enriched his research outcomes but also fostered a collaborative spirit in advancing therapeutic innovations.
Conclusion
Wenhua Huang continues to make strides in the innovation landscape with his pioneering work on anti-Her2 therapies. His patents reflect a deep understanding of the scientific complexities involved and highlight the potential for future breakthroughs in cancer treatment. As he progresses in his career, the impact of his contributions will likely resonate within the medical community, offering hope for improved therapeutic strategies against Her2 positive tumors.